Diabetes & Metabolic Diseases

A Diabetes Class Crosses Into Oncology Outcomes Data

Sonia Reyes
Oncology Care, Healthcare Headlines, Diabetes & Metabolic Diseases, Obesity & Metabolic Health | May 29, 2026
ASCO 2026 analysis of 12,112 patients shows GLP-1 use linked to 31-50% lower stage IV progression in lung, breast, colorectal, and liver cancers.

Online Provider Withdraws Compounded Obesity Pill

George Padron
Healthcare Headlines, Telehealth & Virtual Care, Diabetes & Metabolic Diseases | Feb 8, 2026
Online telehealth provider Hims & Hers has withdrawn its compounded Wegovy pill alternative after federal regulatory scrutiny regarding unapproved absorption technology.

Evidence Supports Statin Label Revision

George Padron
Healthcare Headlines, Cardiovascular Health, Diabetes & Metabolic Diseases | Feb 7, 2026
Meta-analysis of 154,664 participants finds statins cause only liver and urinary changes (<0.1%), not cognitive or renal effects, supporting label revision.

Food Affordability Debates Highlight Nutrition Barriers

George Padron
Oncology Care, Healthcare Headlines, Cardiovascular Health, Public Health Initiatives, Diabetes & Metabolic Diseases | Jan 21, 2026
Agriculture officials suggest $3 meals can meet dietary guidelines, but advocates note that practical barriers affect patient adherence to nutrition guidelines and chronic disease outcomes.

GLP-1 Prescribing Gaps

Sonia Reyes
Healthcare Headlines, Diabetes & Metabolic Diseases | Jan 18, 2026
GLP-1 prescribing lacks behavioral health integration, with physicians failing to discuss psychological and relationship consequences affecting treatment outcomes.